EPIDEMIOLOGICAL, CLINICAL, LABORATORY CHARACTERISTICS AND CARDIOVASCULAR COMPLICATIONS IN CHILDREN WITH KAWASAKI DISEASE AT Children’s Hospital 1 BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC

Tuyết Hoa Lưu1, , Nguyễn Thanh Nhàn Lê1, Thị Hải Yến Phạm1, Thị Bích Ngọc Bùi1, Nguyên Tín Đỗ1,2
1 Bệnh viện Nhi Đồng 1
2 Đại học Y Dược Thành phố Hồ Chí Minh

Main Article Content

Abstract

Objective. To Determine and compare the proportions and mean values of clinical features, laboratory findings, and admission treatments in patients with Kawasaki disease (KD), as well as the prevalence of coronary artery lesions at admission, 2–8 weeks, and 6–12 months after disease onset across the pre–COVID-19, COVID-19, and post-pandemic endemic periods..


Methods. A retrospective descriptive case series including 412 patients aged 0–16 years diagnosed with Kawasaki disease and Kawasaki-like multisystem inflammatory syndrome in children (MIS-C), hospitalized at Children’s Hospital 1 between 01/2019 and 12/ 2023.


Results. Among 412 analyzed cases (90 pre-pandemic, 122 during the pandemic, and 200 in the “new normal” period), the median age increased from 17.5 months pre-pandemic to 23.5 months post-pandemic, while the proportion of children ≥60 months rose from 7.8% to 20.5% (p = 0.002). There were no statistically significant differences in sex distribution or the proportion of incomplete Kawasaki disease across periods. Laboratory findings showed higher rates of hyponatremia (82.6% vs. ~50% previously, p<0.001) and thrombocytopenia (11.3%, p=0.03). Initial corticosteroid use, particularly methylprednisolone, increased post-pandemic (0% to 31.7%, p<0.001). Coronary artery involvement at admission increased across the three periods, although the difference was not statistically significant.


Conclusion. Post–COVID-19, the age at onset was higher, with an increased proportion of children ≥5 years. The male-to-female disparity decreased, while the rate of incomplete Kawasaki disease rose notably during the post-pandemic period.

Article Details

References

1. R. Ae và các cộng sự. (2020), "Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018", J Pediatr. 225, tr. 23-29.e2.
2. R. Ae và các cộng sự. (2022), "Incidence of Kawasaki Disease Before and After the COVID-19 Pandemic in Japan: Results of the 26th Nationwide Survey, 2019 to 2020", JAMA Pediatr. 176(12), tr. 1217-1224.
3. M. Alfalasi và các cộng sự. (2025), "Kawasaki disease in the pre- and post-COVID-19 era: shifts in patterns and outcomes from a multi-center study", Eur J Pediatr. 184(6), tr. 367.
4. Justine Epitaux, Nicole Sekarski và Sabrina Bressieux-Degueldre (2024), "Kawasaki disease before and during the COVID-19 pandemic: a single-center comparative study in Switzerland", BMC Pediatrics. 24(1), tr. 637.
5. Ji-Man Kang và các cộng sự. (2021), "Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea", Circulation. 143(25), tr. 2508-2510.
6. Y. Nakamura, M. Yashiro và H. Yanagawa (2025), "Epidemiology of Kawasaki disease in Japan in 2021-2022: Results of the 27th nationwide survey", Pediatr Int. 67(1), tr. e70007.
7. Duc Long Phi và các cộng sự. (2023), "Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children", J Korean Med Sci. 38(49).